Clinical Chemistry · 2007 · 16 citations · 19 references
MedicineGynecologyObstetricsPrenatal DiagnosisReproductive ImmunologyReproductive MedicineCytokines In ReproductionInflammation In Preterm BirthPlacental ImmunologyPrediction Of Preterm BirthPregnancy DiagnosisScreening For Preterm BirthAssayClinical Utility AssessmentDiagnostic Testing AccuracyInflammation-related BiomarkersLaboratory MarkersPositive Predictive ValuePreterm Delivery Risk AssessmentPreterm Labor Prediction
Abstract Background: Absence of fetal fibronectin (fFN) in the cervicovaginal fluid (CVF) of women with symptoms of preterm labor is an excellent predictor of women who will not deliver within 2 weeks of testing. Preliminary studies suggest interleukin (IL)-6 performs similarly to fFN. The positive predictive values of both these assays are poor. Inconsistent specimen collection may explain this poor performance. The objective of this study was to validate the clinical utility of cervicovaginal IL-6 and investigate the utility of the IL-6:albumin ratio to predict delivery within 14 days. Methods: We quantified albumin and IL-6 with the DPC Immulite® in 660 CVF specimens collected for physician-ordered fFN analysis. The clinical utility of IL-6 and IL-6:albumin to predict delivery within 14 days of collection was determined. Results: The sensitivity, specificity, and positive and negative likelihood ratios for delivery within 14 days were 65%, 87%, 4.8, and 0.4, respectively, for fFN and 35%, 91%, 3.8, and 0.7 for IL-6, with a 250 ng/L cutoff. With a preterm delivery prevalence of 4.7%, positive and negative predictive values were 19% and 98%, respectively, for fFN and 16% and 97% for IL-6. The areas under the ROC curves were 0.71 and 0.51 for IL-6 and IL-6:albumin, respectively. Odds ratios for delivery within 14 days of collection were 11.8 (P <0.0001), 5.5 (P = 0.0001), and 2.4 (P = 0.06) for fFN, IL-6, and IL-6:albumin, respectively. Conclusions: Cervicovaginal IL-6 may have utility for predicting preterm labor while offering the potential for substantial cost savings. Assay performance characteristics are not improved by normalizing IL-6 to albumin.
19
The preterm prediction study: A clinical risk assessment system
B.M. Mercer, Robert L. Goldenberg, A. Das et al. · American Journal of Obstetrics and Gynecology · 1996 · 355 citations
Annual Summary of Vital Statistics: 2004
Donna L. Hoyert, T J Mathews, Fay Menacker et al. · PEDIATRICS · 2006 · 320 citations
Interlukin-1 stimulates prostaglandin biosynthesis by human amnion
Roberto Romero, Scott K. Durum, C A Dinarello et al. · Prostaglandins · 1989 · 300 citations